Awards & Recognition

Mills Recognized for Geriatric Care


Mills-Peninsula Health Services has received a designation for providing specialized care to geriatric patients. The program is called NICHE (Nurses Improving Care for Healthsystem Elders), and provides training for nurses and hospital leadership in issues related to caring for older patients.

The NICHE initiative started at Mills-Peninsula with a grant from the Mills-Peninsula Hospital Foundation to support the specialized training. Jason Overby, an advanced practice nurse who specializes in geriatric care, spearheaded the program after recognizing the need. Read More

Mills Receives Stroke Quality Award

For the fourth year in a row, Mills-Peninsula Health Services has received the American Heart Association/American Stroke Association’s Stroke Gold Plus award, part of the Get With The Guidelines stroke prevention program. The award recognizes Mills-Peninsula for treating stroke patients withStrokeIcon_2014 85 percent or higher compliance to American Heart Association/American Stroke Association standards of care for at least two consecutive years and achieving 75 percent or higher compliance with seven of 10 stroke quality measures in the Get With The Guidelines program. Read More

Mills-Peninsula Receives ‘A’ Grade in Hospital Safety Score

Top of the class

Mills-Peninsula Health Services achieved an “A” grade in the Fall 2013 update to the Leapfrog Group’s Hospital Safety Score, which rates how well hospitals protect patients from accidents, errors, injuries and infections.

Calculated twice per year, the Hospital Safety Score uses 28 measures of publicly available hospital safety data to produce an A, B, C, D or F letter grade reflecting how safe hospitals are for patients. Mills-Peninsula has received “straight A” scores since the inception of the Hospital Safety Score in June 2012. Read More

Mills-Peninsula Honored for Quality Surgical Care

Mills Peninsula Medical Center on March 25, 2011 in Burlingame, Calif.For the second consecutive year, the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) has recognized Mills-Peninsula Health Services for achieving high-quality surgical care. Mills-Peninsula was one of 37 hospitals in the country commended for achieving “meritorious outcome performances” in surgery cases from Jan. 1 -Dec. 31, 2012. Sutter Health affiliates California Pacific Medical Center and Alta Bates Summit Medical Center were also recognized.

“It is a great honor to be recognized as one of the top hospitals in the nation for surgical outcomes,” says Bob Merwin, CEO. “We are proud of the hard work and dedication of our entire team, with special thanks to the outstanding leadership of surgeon Bruce Allen, M.D., and Pat Yadao, surgical nurse reviewer in the Quality Management Department.” Read More

Mills-Peninsula Receives ‘A’ Safety Rating from Leapfrog Group

Mills-Peninsula has received an “A” grade from The Leapfrog Group in its Spring 2013 Hospital Safety Score. This is the third consecutive time Mills-Peninsula has earned an “A” rating for hospital safety from Leapfrog.  The Hospital Safety Score grades general acute care hospitals on how safe they are for patients. It is calculated twice each year using publicly available data on preventable medical errors, injuries, accidents and infections at hospitals.LF2012-t-leapfrog-logo

A panel of patient safety experts provided guidance to The Leapfrog Group to calculate the grades from A to F. The panel selected 26 measures of hospital safety data, analyzed the data and determined the weight of each measure.

Read More

MPHS Diabetes Expert Dr. David Klonoff Elected as AIMBE Fellow

David C. Klonoff, M.D., FACP, medical director of the Diabetes Research Institute at Mills-Peninsula Health Services, has been elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). He will be inducted at the Fellow Induction and Awards Ceremony at AIMBE’s 22nd annual event in February, 2013 in Washington, D.C.

David Klonoff, M.D., Medical Director, Mills-Peninsula Diabetes Research Institute

Being named a Fellow is considered one of the highest honors in the biomedical engineering discipline. Fellows represent the top two percent of the medical and biological engineering community.

AIMBE Fellows are leaders in bioengineering who are working to realize the institute’s vision to provide medical and biological engineering innovation for the benefit of humanity. The AIMBE College of Fellows consists of 1,000 individuals who are the outstanding bioengineers in academia, industry and government. These leaders in the field have distinguished themselves through their contributions in research, industrial practice and/or education.

“The mission of AIMBE is to promote public policies to foster advancement in medical and biological engineering,” Dr. Klonoff said.  “At the Mills-Peninsula Diabetes Research Institute, we are applying advances in medical and bioengineering to develop new products to help people with diabetes. This award will help call attention to our hospital’s efforts to develop novel engineered devices, drug delivery systems and new medications that are safe and effective in the fight against diabetes, which is the world’s greatest epidemic.”

About Dr. David Klonoff

Dr. David Klonoff founded the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services to facilitate development of new devices and drugs for people with diabetes.  He is also a Clinical Professor of Medicine at the University of California, San Francisco (UCSF). Dr. Klonoff’s productivity includes 160 publications, two patents, and 86 clinical trials as principle investigator.  Dr. Klonoff chaired the scientific advisory board for developing the first FDA-approved insulin patch pump and participated in development of the first FDA-approved dedicated diabetes telemedicine system, the first FDA-approved inhaled insulin, and the first three FDA-approved incretin drugs for diabetes.  He is currently the lead investigator for the first-ever randomized controlled multicenter trial of the world’s first artificial pancreas product for outpatient use. Dr. Klonoff has chaired or served on 34 government grant review panels related to diabetes technology, including panels for National Institutes of Health, the Centers for Disease Control and Prevention, NASA, National Science Foundation, U.S. Army, JDRF, and the University of Michigan. 

Read More